Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
10/2002
10/22/2002US6469211 Hydrogenation of nitriles over Raney catalysts
10/17/2002WO2002081425A1 Amine and quaternary ammonium salt derivatives of glycidyl ethers and glycidyl esters
10/17/2002US20020151596 Novel process to prepare 2-aminoindan derivatives
10/17/2002US20020151566 Phosphodiesterase 4 inhibitors
10/17/2002DE10116816A1 Verfahren zur Herstellung von N-Benzylaminen A process for the preparation of N-benzylamines
10/17/2002DE10114970A1 New 1,2-diamino-4-azolyl-, -4-furyl-, -4-thienyl-, -4-phenyl- and -4-azinyl-benzene compounds and known analogues are used in oxidative colorants for keratin fibers, especially human hair
10/17/2002DE10104770C1 (1,1'-Biphenyl)-2,4-diamin-Derivate enthaltende Färbemittel für Keratinfasern sowie neue (1,1'-Biphenyl)-2,4-diamin-Derivate (1,1'-biphenyl) -2,4-diamine derivatives containing a colorant for keratin fibers and new (1,1'-biphenyl) -2,4-diamine derivatives
10/16/2002WO2001089505A1 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
10/16/2002EP1248777A2 Tricyclic compounds with antiviral activity
10/16/2002CN1092705C Polyalkyl phenoxyaminoalkanes and fuel compositions containing same
10/16/2002CN1092630C Process for alkoxylation of fluorinated alcohols
10/16/2002CA2406198A1 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
10/15/2002US6465694 Method for preparation of polyethylene glycol aldehyde derivatives
10/15/2002US6465419 Esters derived from alkanolamines, dicarboxylic acids and fatty alcohols and the cationic surfactants obtainable therefrom
10/15/2002US6465223 Enzyme-catalyzed racemic cleavage of primary amines
10/10/2002WO2002078693A2 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
10/10/2002WO2002057215A3 Sodium channel modulators
10/10/2002WO2002005745A3 The process of manufacturing pharmaceutical grade tannates
10/10/2002WO2001072685A9 Polyamine analogues as cytotoxic agents
10/10/2002US20020147366 Alkoxylated tertiary and quaternary amine surfactants
10/10/2002US20020147127 Cosmetics, cleaning compounds
10/10/2002US20020144700 Couplers for oxidative coloration of hair
10/10/2002US20020144361 Novel couplers for use in oxidative hair dyeing
10/10/2002US20020144358 2-substituted-4-amino-phenol derivative compounds providing good oxidative coloration of hair and acceptable light fastness, fastness to shampooing and permanent wave treatment
10/10/2002US20020144357 Benzene-1,4-diamine compounds having a weaker sensitization potential than p-phenylenediamine
10/10/2002US20020144355 Primary intermediates for oxidative coloration of hair
10/09/2002EP1247799A2 Process for the preparation of N-benzylamines
10/09/2002EP1246793A2 Substituted aminomethyl-phenyl-cyclohexane derivatives
10/09/2002EP1246790A1 Substituted 1 and 2 naphthol mannich bases
10/09/2002CN1373745A 3-amino-2-benzyl-1-phenyl-propane derivs.
10/08/2002US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases
10/03/2002WO2002076995A2 2-amino-propanol derivatives
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002WO2002076924A1 Ionic liquid, electrolyte salt for storage device, electrolytic solution for storage device, electric double layer capacitor, and secondary battery
10/03/2002WO2002076923A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds
10/03/2002WO2002076916A1 Self-reducing anthraquinone compounds
10/03/2002WO2002058631A3 Primary intermediates for oxidative coloration of hair
10/03/2002US20020143212 Process for producing optically active 3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid, and salt thereof
10/03/2002US20020143211 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochlorid, processes for preparing thereof
10/03/2002US20020143003 As serotonin, norepinephrine and dopamine reuptake inhibitors, for therapy of central nervous system and other disorders
10/03/2002US20020138919 Novel couplers for use in oxidative hair dyeing
10/03/2002CA2443289A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds
10/03/2002CA2442178A1 2-amino-propanol derivatives
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/02/2002EP1245249A2 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/02/2002CN1372465A Antimycotic drug
10/01/2002US6458999 Derivatives of novel ether diamine compounds prepared by the cyanobutylation reaction of an alcohol ether nitrile. the etheraminonitriles formed by the process are hydrogenated to form alkylether amines.
10/01/2002US6458955 Preparation of high enantiomeric purity compounds center on resolution using simulated moving bed chromatography of a racemic precursor early in the synthesis. resolution is effected with high enantiomeric purity, and subsequent
10/01/2002US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes
10/01/2002US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
09/2002
09/26/2002WO2002074726A2 Aniline derivatives useful as phosphodiesterase 4 inhibitors
09/26/2002WO2002057201A3 Polymerizable higher diamondoid derivatives
09/26/2002WO2002018334B1 Sodium channel modulators
09/26/2002DE10114084A1 New 1,3-diamino-4-aminomethyl-benzene derivatives, useful as coupler substances in oxidative hair dye formulations based on a developer-coupler combination
09/26/2002CA2435847A1 Aniline derivatives useful as phosphodiesterase 4 inhibitors
09/25/2002EP1242362A1 Process for the preparation of fluoxetine hydrochloride
09/25/2002EP1242361A1 Process of preparing tolterodine and analogues there of as well as intermediates prepared in the process
09/25/2002EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides
09/25/2002CN1371360A Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof
09/25/2002CN1371277A Pharmaceutical tramadol salts
09/24/2002US6455736 Process for preparation of pharmaceutically desired sertraline and sertraline analogs
09/24/2002US6455727 Heating and agitating mixtures of tannins and carbetapentane, then milling to form free-flowing powder; antihistamines
09/24/2002US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/24/2002CA2027396C Catalytic method for the reductive amination of poly (oxytetramethylene) glycols
09/19/2002WO2002072760A2 Pcra helicase inhibitors
09/19/2002WO2002072542A2 Ph-dependent nmda receptor antagonists
09/19/2002WO2002072083A1 Novel inhibitors of formation of advanced glycation endproducts (ages)
09/19/2002WO2002072068A2 Lipids, lipid compositions, liposomes, and lipoplexes
09/19/2002WO2002062308A3 Primary intermediates for oxidative coloration of hair
09/19/2002US20020133007 Potato and corn crops
09/19/2002CA2440284A1 Ph-dependent nmda receptor antagonists
09/18/2002EP0804427B1 Lta4 hydrolase inhibitors
09/17/2002US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451740 Uracil compounds and use thereof
09/12/2002WO2002070457A1 Inhibitor of monoamine uptake
09/12/2002WO2002070456A1 Benzene-1 2-diol mannich bases ligands polymers and method of selective metal ions removal
09/12/2002WO2002050077A3 Triazolopyrimidines
09/12/2002US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
09/12/2002US20020128231 Aryl-indane compounds
09/12/2002US20020124326 Contacting the substrate with a mono-, di-, or trialkoxy-substituted perfluoroalkane, perfluorocycloalkane, or perfluorocycloalkyl(ene)- containing perfluoroalkane
09/12/2002CA2440161A1 Inhibitor of monoamine uptake
09/12/2002CA2439634A1 Benzene-1 2-diol mannich bases ligands polymers and method of selective metal ions removal
09/11/2002EP1237879A1 Phenoxy and thiophenoxy acrylic acid compounds as herbicides
09/11/2002EP1237874A2 Selective neurokinin antagonists
09/11/2002EP1237857A1 New phenalkyloxy-phenyl derivatives
09/11/2002EP0769942B1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
09/11/2002CN1368956A Carbamate derivatives and agricultural/horticultural bactericides
09/11/2002CN1090637C Cross-link cinnamic acid derivative and its preparation method
09/10/2002US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein
09/10/2002US6448294 Biphenyl compounds and their use as oestrogenic agents
09/10/2002US6448293 Treatment or prevention of a disorder in which the regulation of monoamine transporter function is implicated, such as premature ejaculation.
09/06/2002WO2002068504A1 Oxalkylation products produced from epoxides and amines and their use in pigment preparations
09/06/2002WO2002067916A2 Pharmaceutical salts
09/06/2002WO2002067651A2 Pharmaceutical salts
09/06/2002WO2002014344A3 Amino acid-derived cyclic phosphonamides and methods of synthesizing the same
09/06/2002CA2725635A1 Pharmaceutical salts of 6-dimethylaminomethyl-1-phenylcyclohexane compounds
09/05/2002US20020123652 2-aminotetralines and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
09/05/2002US20020123491 Selective neurokinin antagonists
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 140